Comparing Aflibercept Monotherapy With Aflibercept Plus Rescue Photodynamic Therapy in Polypoidal Choroidal Vasculopathy
Open Access
- 1 July 2018
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 136 (7) , 794-795
Abstract
In this issue, Lee et al report the 52-week results of the PLANET study, a randomized clinical trial comparing intravitreal aflibercept (IVA) monotherapy with IKeywords
This publication has 6 references indexed in Scilit:
- Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal VasculopathyJAMA Ophthalmology, 2017
- Comparison of the 1-year Outcomes of Conbercept Therapy between Two Different Angiographic Subtypes of Polypoidal Choroidal VasculopathyChinese Medical Journal, 2016
- Safety and Efficacy of Conbercept in Neovascular Age-Related Macular DegenerationOphthalmology, 2014
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular DegenerationOphthalmology, 2012
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumabAngiogenesis, 2012
- Predicted biological activity of intravitreal VEGF TrapBritish Journal of Ophthalmology, 2008